| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.03B | 25.35B | 18.74B | 11.37B | 10.44B | 9.86B |
| Gross Profit | 3.46B | 2.98B | 2.80B | 2.20B | 1.44B | 984.00M |
| EBITDA | 2.06B | 1.25B | 8.66B | 5.55B | 5.03B | 4.67B |
| Net Income | 651.00M | 683.60M | 816.20M | 1.22B | 873.00M | 509.80M |
Balance Sheet | ||||||
| Total Assets | 73.10B | 150.23B | 70.26B | 31.30B | 26.99B | 25.07B |
| Cash, Cash Equivalents and Short-Term Investments | 7.13B | 5.47B | 4.84B | 584.70M | 533.40M | 545.10M |
| Total Debt | 37.89B | 40.14B | 37.88B | 19.99B | 18.64B | 17.78B |
| Total Liabilities | 61.91B | 139.07B | 58.91B | 24.39B | 22.15B | 20.87B |
| Stockholders Equity | 11.16B | 11.13B | 10.83B | 6.88B | 4.81B | 4.16B |
Cash Flow | ||||||
| Free Cash Flow | -4.16B | -11.00B | -3.27B | -4.71B | -3.78B | -2.56B |
| Operating Cash Flow | 7.35B | 10.80B | -2.99B | 4.95B | 5.08B | 4.71B |
| Investing Cash Flow | -6.72B | -2.04B | 754.50M | -6.62B | -5.57B | -2.70M |
| Financing Cash Flow | -3.08B | 2.23B | 5.71B | 1.97B | 537.90M | -737.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $5.87B | 15.75 | 10.25% | 1.78% | 4.83% | 52.47% | |
74 Outperform | €10.92B | 10.92 | 14.39% | 4.18% | 7.71% | -2.82% | |
70 Outperform | €7.87B | 39.03 | 10.66% | 2.23% | 10.87% | -10.35% | |
67 Neutral | €8.34B | 33.62 | 4.63% | 4.15% | 2.16% | -64.02% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | €10.09B | 71.62 | 1.54% | ― | 4.94% | ― | |
61 Neutral | €8.70B | 10.90 | 7.26% | 3.59% | 5.22% | 35.25% |